-
Mashup Score: 16Assessing the safety of physical rehabilitation in critically ill patients: a Delphi study - Critical Care - 12 hour(s) ago
Background Physical rehabilitation of critically ill patients is implemented to improve physical outcomes from an intensive care stay. However, before rehabilitation is implemented, a risk assessment is essential, based on robust safety data. To develop this information, a uniform definition of relevant adverse events is required. The assessment of cardiovascular stability is particularly relevant before physical activity as there is uncertainty over when it is safe to start rehabilitation with patients receiving vasoactive drugs. Methods A three-stage Delphi study was carried out to (a) define adverse events for a general ICU cohort, and (b) to define which risks should be assessed before physical rehabilitation of patients receiving vasoactive drugs. An international group of intensive care clinicians and clinician researchers took part. Former ICU patients and their family members/carers were involved in generating consensus for the definition of adverse events. Round one was an ope
Source: ccforum.biomedcentral.comCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 61Stress & strain in mechanically nonuniform alveoli using clinical input variables: a simple conceptual model - Critical Care - 2 day(s) ago
Clinicians currently monitor pressure and volume at the airway opening, assuming that these observations relate closely to stresses and strains at the micro level. Indeed, this assumption forms the basis of current approaches to lung protective ventilation. Nonetheless, although the airway pressure applied under static conditions may be the same everywhere in healthy lungs, the stresses within a mechanically non-uniform ARDS lung are not. Estimating actual tissue stresses and strains that occur in a mechanically non-uniform environment must account for factors beyond the measurements from the ventilator circuit of airway pressures, tidal volume, and total mechanical power. A first conceptual step for the clinician to better define the VILI hazard requires consideration of lung unit tension, stress focusing, and intracycle power concentration. With reasonable approximations, better understanding of the value and limitations of presently used general guidelines for lung protection may ev
Source: ccforum.biomedcentral.comCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 4Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trials - Critical Care - 3 day(s) ago
Acute kidney injury (AKI) often complicates sepsis and is associated with high morbidity and mortality. In recent years, several important clinical trials have improved our understanding of sepsis-associated AKI (SA-AKI) and impacted clinical care. Advances in sub-phenotyping of sepsis and AKI and clinical trial design offer unprecedented opportunities to fill gaps in knowledge and generate better evidence for improving the outcome of critically ill patients with SA-AKI. In this manuscript, we review the recent literature of clinical trials in sepsis with focus on studies that explore SA-AKI as a primary or secondary outcome. We discuss lessons learned and potential opportunities to improve the design of clinical trials and generate actionable evidence in future research. We specifically discuss the role of enrichment strategies to target populations that are most likely to derive benefit and the importance of patient-centered clinical trial endpoints and appropriate trial designs with
Source: ccforum.biomedcentral.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 93Fluid responsiveness and venous congestion: unraveling the nuances of fluid status - Critical Care - 3 day(s) ago
The concept of fluid tolerance, which refers to the capacity of patients to undergo fluid expansion without experiencing harmful effects of volume overload with organ dysfunction, is gaining recognition in both intensive care literature [1] and clinical practice, driven by the mounting evidence of the detrimental impacts of fluid overload [2]. It physiologically makes sense that systemic venous return can still increase even when some degree of venous congestion is already present. In the past, Patterson
Source: ccforum.biomedcentral.comCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 39
Background Patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-COV 2) and requiring mechanical ventilation suffer from a high incidence of ventilator associated pneumonia (VAP), mainly related to Enterobacterales. Data regarding extended-spectrum beta-lactamase producing Enterobacterales (ESBL-E) VAP are scarce. We aimed to investigate risk factors and outcomes of ESBL-E related VAP among critically ill coronavirus infectious disease-19 (COVID-19) patients who developed Enterobacterales related VAP. Patients and methods We performed an ancillary analysis of a multicenter prospective international cohort study (COVID-ICU) that included 4929 COVID-19 critically ill patients. For the present analysis, only patients with complete data regarding resistance status of the first episode of Enterobacterales related VAP (ESBL-E and/or carbapenem-resistant Enterobacterales, CRE) and outcome were included. Results We included 591 patients with Enterobacterales related
Source: ccforum.biomedcentral.comCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 36
Background Angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blockers (ARB) medications are widely prescribed. We sought to assess how pre-admission use of these medications might impact the response to angiotensin-II treatment during vasodilatory shock. Methods In a post-hoc subgroup analysis of the randomized, placebo-controlled, Angiotensin Therapy for High Output Shock (ATHOS-3) trial, we compared patients with chronic angiotensin-converting enzyme inhibitor (ACEi) use, and patients with angiotensin receptor blocker (ARB) use, to patients without exposure to either ACEi or ARB. The primary outcome was mean arterial pressure after 1-h of treatment. Additional clinical outcomes included mean arterial pressure and norepinephrine equivalent dose requirements over time, and study-drug dose over time. Biological outcomes included baseline RAS biomarkers (renin, angiotensin-I, angiotensin-II, and angiotensin-I/angiotensin-II ratio), and the change in renin from 0 to
Source: ccforum.biomedcentral.comCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 27
Background It is unclear how often survival benefits observed in single-center randomized controlled trials (sRCTs) involving critically ill patients are confirmed by subsequent multicenter randomized controlled trials (mRCTs). We aimed to perform a systemic literature review of sRCTs with a statistically significant mortality reduction and to evaluate whether subsequent mRCTs confirmed such reduction. Methods We searched PubMed for sRCTs published in the New England Journal of Medicine, JAMA, or Lancet, from inception until December 31, 2016. We selected studies reporting a statistically significant mortality decrease using any intervention (drug, technique, or strategy) in adult critically ill patients. We then searched for subsequent mRCTs addressing the same research question tested by the sRCT. We compared the concordance of results between sRCTs and mRCTs when any mRCT was available. We registered this systematic review in the PROSPERO International Prospective Register of System
Source: ccforum.biomedcentral.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 27
Background It is unclear how often survival benefits observed in single-center randomized controlled trials (sRCTs) involving critically ill patients are confirmed by subsequent multicenter randomized controlled trials (mRCTs). We aimed to perform a systemic literature review of sRCTs with a statistically significant mortality reduction and to evaluate whether subsequent mRCTs confirmed such reduction. Methods We searched PubMed for sRCTs published in the New England Journal of Medicine, JAMA, or Lancet, from inception until December 31, 2016. We selected studies reporting a statistically significant mortality decrease using any intervention (drug, technique, or strategy) in adult critically ill patients. We then searched for subsequent mRCTs addressing the same research question tested by the sRCT. We compared the concordance of results between sRCTs and mRCTs when any mRCT was available. We registered this systematic review in the PROSPERO International Prospective Register of System
Source: ccforum.biomedcentral.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 60Significance of critical closing pressures (starling resistors) in arterial circulation - Critical Care - 14 day(s) ago
Arterial pressure is the input pressure driving tissue blood flow. However, under most conditions organ blood flow is independent of arterial pressure. Tissue blood flow is proportional to local metabolic demand and can vary widely without any change in arterial pressure. Furthermore, changes in arterial pressure within physiologic limits do not alter tissue blood flow. The reason for these apparent incongruities derive from the determinants of organ blood flow. Tissues autoregulate their levels of
Source: ccforum.biomedcentral.comCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 16
Background To perform a systematic review with meta-analysis with the dual intent of assessing the impact of attaining aggressive vs. conservative beta-lactams PK/PD target on the clinical efficacy for treating Gram-negative infections in critical patients, and of identifying predictive factors of failure in attaining aggressive PK/PD targets. Methods Two authors independently searched PubMed-MEDLINE and Scopus database from inception to 23rd December 2023, to retrieve studies comparing the impact of attaining aggressive vs. conservative PK/PD targets on clinical efficacy of beta-lactams. Independent predictive factors of failure in attaining aggressive PK/PD targets were also assessed. Aggressive PK/PD target was considered a100%fT>4xMIC, and clinical cure rate was selected as primary outcome. Meta-analysis was performed by pooling odds ratios (ORs) extrapolated from studies providing adjustment for confounders using a random-effects model with inverse variance method. Results A total
Source: ccforum.biomedcentral.comCategories: General Medicine News, Critical CareTweet-
#CritCare #OpenAccess Impact of attaining aggressive vs conservative PK/PD target on the clinical efficacy of beta-lactams for the treatment of Gram-negative infections in critically ill patients Read the full article: https://t.co/emNRvvSqXg @jlvincen @ISICEM #FOAMed #FOAMcc https://t.co/14GfHNvkhE
-
#CritCare #OpenAccess Assessing the safety of physical rehabilitation in critically ill patients: a Delphi study Read the full article: https://t.co/yODWw7RJyM @jlvincen @ISICEM #FOAMed #FOAMcc https://t.co/kgIyIcobQj